Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06075264What this trial is testingPhase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)Who this might be right forVulvar DiseasesHPV InfectionVulvar HSIL+10 more Frantz Viral Therapeutics, LLC 27
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00003704What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerWho this might be right forCancer Alliance for Clinical Trials in Oncology 51
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Not applicableStudy completedNCT00504023What this trial is testingTopical Imiquimod in Treating Patients With Recurrent Paget's Disease of the VulvaWho this might be right forVulvar Cancer Memorial Sloan Kettering Cancer Center 8
Large-scale testing (Phase 3)Ended earlyNCT00006096What this trial is testingRadiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the VulvaWho this might be right forVulvar Cancer Gynecologic Oncology Group
Early research (Phase 1)Looking for participantsNCT04169763What this trial is testingNelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by SurgeryWho this might be right forStage II Vulvar Cancer AJCC v8Stage III Vulvar Cancer AJCC v8Stage IIIA Vulvar Cancer AJCC v8+3 more M.D. Anderson Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT00033605What this trial is testingOctreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the PelvisWho this might be right forCervical CancerColorectal CancerDiarrhea+8 more Alliance for Clinical Trials in Oncology 130
Not applicableStudy completedNCT03339765What this trial is testingSelf-Advocacy Serious Game in Advanced CancerWho this might be right forOvarian Cancer Stage IIIOvarian Cancer Stage IVBreast Cancer Stage IV+10 more University of Pittsburgh 78
Large-scale testing (Phase 3)Study completedNCT01047345What this trial is testingV503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)Who this might be right forCervical CancersVulvar CancersVaginal Cancers+1 more Merck Sharp & Dohme LLC 924
Not applicableUnknownNCT00956670What this trial is testingLymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar CancerWho this might be right forLymphedemaStage IA Cervical CancerStage IA Uterine Corpus Cancer+11 more Gynecologic Oncology Group 1,055
Testing effectiveness (Phase 2)WithdrawnNCT03220009What this trial is testingNivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWho this might be right forCervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00014599What this trial is testingPaclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the VulvaWho this might be right forVulvar Cancer European Organisation for Research and Treatment of Cancer - EORTC 31
Not applicableUnknownNCT00601406What this trial is testingStudy of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerWho this might be right forBreast CancerCervical CancerEndometrial Cancer+7 more The Christie NHS Foundation Trust 2,200
Not applicableStudy completedNCT04269837What this trial is testingSexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic CancerWho this might be right forMalignant Female Reproductive System NeoplasmStage I Cervical Cancer AJCC v8Stage I Uterine Corpus Cancer AJCC v8+42 more Ohio State University Comprehensive Cancer Center 4